- Home
- INDP vs AIOS Comparison
INDP vs AIOS Comparison
Compare INDP & AIOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.75
N/A
Current Price
$0.60
Company Overview
Basic Information| Metric | INDP | AIOS |
|---|---|---|
| Founded | 2000 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5M | 4.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | INDP | AIOS |
|---|---|---|
| Price | $1.75 | $0.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 19.2K | ★ 1.2M |
| Earning Date | 03-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.27 | $0.43 |
| 52 Week High | $13.24 | $0.88 |
Technical Indicators
Market Signals| Indicator | INDP | AIOS |
|---|---|---|
| Relative Strength Index (RSI) | 39.06 | 48.16 |
| Support Level | $0.27 | $0.58 |
| Resistance Level | $2.18 | $0.73 |
| Average True Range (ATR) | 0.15 | 0.11 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 5.06 | 25.35 |
Price Performance
Historical Comparison INDP
AIOS
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.